Statement by Amb. Michael Marine, CEO of the Sabin Vaccine Institute, on the Passing of Morton P. Hyman

Morton P. Hyman, a renowned philanthropic and public health leader and Chariman of the Sabin Vaccine Institute Board of Trustees, passed away peacefully yesterday surrounded by his family and loved ones. The following is a statement from Sabin’s CEO, Ambassador Michael W. Marine, reflecting on the profound difference that Mort made during his lifetime.

Dr. Jon Andrus Named Executive Vice President of the Sabin Vaccine Institute

WASHINGTON, D.C. — September 25, 2014 — The Sabin Vaccine Institute (Sabin) today announced that effective October 17, 2014, Dr. Jon Andrus will join Sabin as Executive Vice President and Director of Vaccine Advocacy and Education. In this role, he will leverage more than three decades of experience as a global health leader with a well-documented record for fostering collaboration among national governments and partners to expand access to vaccines for the world’s poorest people.

International Association of Immunization Managers Holds Inaugural Regional Meeting

Durban, South Africa — 22 September 2014 — The International Association of Immunization Managers (IAIM) Secretariat, based at the Sabin Vaccine Institute (Sabin), today announced it will hold its first-ever regional meeting for members from the Middle East and Africa on 25-26 September 2014 in Durban, South Africa.

Sabin Vaccine Institute Awarded Funding to Advance Therapeutic Vaccine Development for Chagas Disease

WASHINGTON, D.C. — September 16, 2014 — The Sabin Vaccine Institute (Sabin) today announced that its product development partnership (Sabin PDP) received $2 million from the Global Health Innovative Technology Fund (GHIT Fund) to develop a new therapeutic vaccine formulation for Chagas disease. Baylor College of Medicine, Eisai Co., Ltd. (Eisai) and Aeras are partnering on this project with the Sabin PDP, based at the Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development in Houston, Texas.

Phase 1 Clinical Trial of Human Hookworm Vaccine Successfully Completed

WASHINGTON, D.C. — September 3, 2014 — The Sabin Vaccine Institute (Sabin) today announced that its product development partnership (Sabin PDP) successfully completed a Phase 1 clinical trial in Brazil of Na-GST-1/Alhydrogel®, a vaccine candidate for human hookworm, one of the most pervasive neglected tropical diseases (NTDs) affecting the world’s poor. The Sabin PDP is based at Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development at Baylor College of Medicine in Houston, Texas.

Eleventh International Rotavirus Symposium Held in New Delhi, India

New Delhi, India — September 3, 2014 — The Eleventh International Rotavirus Symposium today began just two months after Indian Prime Minister Narendra Modi announced that the Government of India would provide a rotavirus vaccine to all Indian children, and weeks before the highly anticipated UN General Assembly’s 69th opening session, which will assess progress towards the Millennium Development Goals (MDGs).

Statement by the Sabin Vaccine Institute on the introduction of the “End Neglected Tropical Diseases Act”

On June 11, 2014, Congressman Chris Smith (R-NJ) introduced a bipartisan bill in the House of Representatives to support the control and elimination of neglected tropical diseases (NTDs) in the United States and abroad. H.R. 4847, the “End Neglected Tropical Diseases Act,” calls for the expansion of USAID’s NTD program; increased U.S. Government advocacy for NTDs among international development and financing institutions; reporting from the U.S. Department of Health and Human Services on NTDs in the United States; the creation of one or more NTD centers of excellence to increase research and development (R&D); and the establishment of a panel on intestinal worm infections, one of the most pervasive NTDs.

Statements by the Sabin Vaccine Institute on the passing of Executive Vice President Ciro de Quadros, MD

Dr. Ciro de Quadros, a public health hero and the Sabin Vaccine Institute’s Executive Vice President and Director of Vaccine Advocacy and Education, passed away peacefully today at his home in Washington, DC, surrounded by his family. The following are statements from Sabin’s executive leadership reflecting on the profound difference that Ciro made during his lifetime.

Statement by the Sabin Vaccine Institute: A rare spotlight for a neglected disease

Schistosomiasis, a parasitic disease transmitted by freshwater snails, infects more than 200 million people worldwide, causing horrific symptoms, especially in girls and women. Schistosomiasis is the second deadliest parasitic disease after malaria, killing an estimated 300,000 people annually, and has been linked as a co-factor in the spread of HIV/AIDS in sub-Saharan Africa and the incidence of bladder cancer.

Pages